Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
59.68 GBX | +8.51% | -4.51% | -1.36% |
Apr. 17 | North American Morning Briefing : Stock Futures -2- | DJ |
Mar. 26 | EARNINGS: CAB Payments profit drops, Life Science REIT cuts dividend | AN |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 232.8 | 217.7 | 221.9 | 150.7 | 100.9 | 91.7 | - | - |
Enterprise Value (EV) 1 | 230.2 | 219.6 | 209.8 | 135.6 | 84.97 | 78.69 | 77.61 | 73.31 |
P/E ratio | -18.9 x | 53.3 x | 30.3 x | 19.8 x | 17.5 x | 16.9 x | 15.1 x | 13.4 x |
Yield | - | - | - | 0.67% | 1.98% | 2.62% | 2.59% | 3.08% |
Capitalization / Revenue | 2.17 x | 2.64 x | 1.93 x | 1.12 x | 0.81 x | 0.72 x | 0.69 x | 0.67 x |
EV / Revenue | 2.15 x | 2.67 x | 1.82 x | 1.01 x | 0.68 x | 0.62 x | 0.59 x | 0.54 x |
EV / EBITDA | 15.2 x | 22.5 x | 13.6 x | 7.52 x | 5.32 x | 4.65 x | 4.38 x | 3.89 x |
EV / FCF | -41.1 x | 462 x | 31.3 x | 29.4 x | 15.1 x | 15.4 x | 15.5 x | 13 x |
FCF Yield | -2.43% | 0.22% | 3.19% | 3.4% | 6.61% | 6.48% | 6.46% | 7.69% |
Price to Book | 3.7 x | 3.28 x | 2.97 x | 1.76 x | 1.14 x | 1.04 x | 0.98 x | 0.93 x |
Nbr of stocks (in thousands) | 167,451 | 167,451 | 167,451 | 167,451 | 166,735 | 166,735 | - | - |
Reference price 2 | 1.390 | 1.300 | 1.325 | 0.9000 | 0.6050 | 0.5500 | 0.5500 | 0.5500 |
Announcement Date | 4/8/20 | 3/23/21 | 3/22/22 | 3/21/23 | 3/19/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 107.2 | 82.37 | 115.1 | 134 | 124.2 | 127.9 | 132 | 136.3 |
EBITDA 1 | 15.17 | 9.755 | 15.38 | 18.04 | 15.98 | 16.93 | 17.74 | 18.87 |
EBIT 1 | 13 | 6.8 | 11.5 | 12.9 | 10.45 | 12.7 | 12.99 | 14.34 |
Operating Margin | 12.13% | 8.26% | 9.99% | 9.62% | 8.41% | 9.93% | 9.84% | 10.51% |
Earnings before Tax (EBT) 1 | -10.29 | 4.969 | 9.317 | 9.703 | 7.409 | 7.272 | 8.135 | 8.926 |
Net income 1 | -12.32 | 4.08 | 7.347 | 7.613 | 5.795 | 5.42 | 5.976 | 6.517 |
Net margin | -11.5% | 4.95% | 6.38% | 5.68% | 4.67% | 4.24% | 4.53% | 4.78% |
EPS 2 | -0.0736 | 0.0244 | 0.0438 | 0.0454 | 0.0345 | 0.0326 | 0.0365 | 0.0410 |
Free Cash Flow 1 | -5.596 | 0.475 | 6.701 | 4.608 | 5.621 | 5.096 | 5.01 | 5.638 |
FCF margin | -5.22% | 0.58% | 5.82% | 3.44% | 4.53% | 3.98% | 3.8% | 4.14% |
FCF Conversion (EBITDA) | - | 4.87% | 43.58% | 25.54% | 35.18% | 30.1% | 28.24% | 29.88% |
FCF Conversion (Net income) | - | 11.64% | 91.21% | 60.53% | 97% | 94.01% | 83.83% | 86.51% |
Dividend per Share 2 | - | - | - | 0.006000 | 0.0120 | 0.0144 | 0.0142 | 0.0170 |
Announcement Date | 4/8/20 | 3/23/21 | 3/22/22 | 3/21/23 | 3/19/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | 1.91 | - | - | - | - | - | - |
Net Cash position 1 | 2.52 | - | 12.1 | 15.1 | 15.9 | 13 | 14.1 | 18.4 |
Leverage (Debt/EBITDA) | - | 0.1961 x | - | - | - | - | - | - |
Free Cash Flow 1 | -5.6 | 0.48 | 6.7 | 4.61 | 5.62 | 5.1 | 5.01 | 5.64 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | 0.3800 | 0.4000 | 0.4500 | 0.5100 | 0.5300 | 0.5300 | 0.5600 | 0.5900 |
Cash Flow per Share 2 | -0.0400 | 0.0400 | 0.0700 | 0.0800 | 0.0800 | 0.0800 | 0.0900 | 0.0900 |
Capex 1 | 2.09 | 5.68 | 5.28 | 8.38 | 8.53 | 7.8 | 7.68 | 7.9 |
Capex / Sales | 1.95% | 6.89% | 4.59% | 6.25% | 6.87% | 6.1% | 5.81% | 5.79% |
Announcement Date | 4/8/20 | 3/23/21 | 3/22/22 | 3/21/23 | 3/19/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.09% | 115M | |
+24.46% | 27.92B | |
+10.84% | 18.78B | |
+10.92% | 13.98B | |
-3.71% | 11.86B | |
+8.53% | 11B | |
+9.56% | 4.54B | |
-9.36% | 3.87B | |
+36.33% | 3.42B | |
+11.82% | 3.32B |
- Stock Market
- Equities
- PEBB Stock
- Financials The Pebble Group plc